Last reviewed · How we verify

NCT02684500

Aneurysmal Subarachnoid Hemorrhage and Superior Mesenteric Artery Flow Study

Completed Last updated 19 March 2020
What this trial tests

trial testing Ultrasound in Intracranial Aneurysm in 14 participants. Completed in 30 June 2016.

Timeline
11 April 2016
Primary endpoint
30 June 2016
30 June 2016

Quick facts

Lead sponsorUniversity of Florida
StatusCompleted
Study typeOBSERVATIONAL
Enrollment14
Start date11 April 2016
Primary completion30 June 2016
Estimated completion30 June 2016
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Florida

Who can join

Adults 18 to 99, any sex, with Intracranial Aneurysm. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this research study is to determine if the diameter and flow of the superior mesenteric artery in patients with aneurysmal subarachnoid hemorrhage undergoing hypertensive therapy for cerebral artery vasospasm are effected enough to justify withholding enteral nutrition.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Ultrasound

Trials testing the same drug.

Other recruiting trials for Intracranial Aneurysm

Currently open trials in the same condition.

Other University of Florida trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02684500.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing